Chronic stress is epidemic, and it is killing us. We know that and strive to become healthier. For some people that can be ...

Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

The creation of a “Make America Healthy Again Commission” has raised concerns over Washington youths' access to medications ...

If you or a loved one has been diagnosed with schizophrenia, here’s what to know about the causes of cognitive symptoms, their health effects, and how to manage them. “These difficulties could ...

Ketamine can trigger symptoms similar to those of schizophrenia, but it isn’t known to cause the disorder itself. Ketamine is gaining attention for its potential to treat depression and other ...

Those with the disorder experience symptoms of schizophrenia such as delusions, hallucinations, disorganised speech and cognitive impairment; together with symptoms of disordered mood such as ...

Lexapro (escitalopram) and Zoloft (sertraline) are two prescription medications classified as selective serotonin reuptake inhibitors (SSRIs) used to treat mood disorders, like depression and anxiety.

About 10% of new cases could have been avoided if people hospitalized for weed use quit toking WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Schizophrenia cases associated with problematic weed use have ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Schizophrenia cases associated with problematic weed use have skyrocketed in the wake of Canada's legalization of marijuana, a new study says.

Canada’s legalization of cannabis has been linked to an increase in schizophrenia cases, new research shows. Over a 16-year time period — spanning before and after legalization of cannabis for ...

The proportion of new cases of schizophrenia associated with a cannabis use disorder has risen from 4% pre-legalization to 10% after cannabis legalization in Ontario, according to new research. A ...

The proportion of new schizophrenia cases linked to cannabis use has nearly tripled in almost two decades, increasing gradually as access to the drug was expanded for medical and later ...